Claim Missing Document
Check
Articles

Analysis of the Effectiveness of Oral Antidiabetic Therapy on HbA1c Control in Type 2 Diabetes Mellitus Patients: Analisis Efektivitas Terapi Antidiabetes Oral terhadap Pengendalian Kadar HbA1c pada Pasien Diabetes Mellitus Tipe 2 Chinthia Devientasari; Selly Septi Fandinata; Dini Berliana; Anggi Restyana; Luluk Aniqoh Meliana Putri; Devita Riafinola Andaririt
Journal Pharmasci (Journal of Pharmacy and Science) Vol. 11 No. 2 (2026): Journal Pharmasci (Journal of Pharmacy and Science)
Publisher : Akademi Farmasi Surabaya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.53342/pharmasci.v11i2.595

Abstract

Effective glycemic control is crucial for preventing chronic complications in patients with type 2 diabetes mellitus (T2DM). HbA1c levels are one of the best indicators that can be used to evaluate the success of pharmacological therapy in the long term. The purpose of this study was to analyze the effectiveness of oral antidiabetic use in reducing HbA1c levels in T2DM patients. This study used an observational quasi-experimental design with a one-group pre-post test approach conducted on 100 respondents. Statistical analysis used a paired sample t-test with a significance level of 95% (? = 0.05). The data used included demographic profiles and HbA1c levels before and after oral antidiabetic therapy intervention. The results showed that the average HbA1c level before therapy was 6.85 ± 1.54%, while after therapy it became 6.40 ± 1.22%. There was a decrease in the average HbA1c by 0.45%. The results of the Paired Sample t-Test showed a p value = 0.002 (p < 0.05), indicating a significant difference between HbA1c levels before and after therapy. In addition, the proportion of patients with poorly controlled HbA1c decreased from 15% to 5% after therapy. The conclusion of this study is that a significant decrease in HbA1c levels indicates that oral antidiabetic therapy can help achieve glycemic control targets and potentially reduce the risk of long-term diabetes complications.
Co-Authors Alfiana, Silvina Sita Amriani, Annisa Andik Isdianto Anggi Restyana Anita Purnamayanti Annisa Amriani Anri Wani Pahkoib Arel Mitra Anjeli Wagho Aristyawan, Andhika Dwi Aryanda Putra, Deddy Berliana, Dini Cahya Aprilia Harwoko Chinthia Devientasari Dabyt Faizin Firzatullah Deddy Aryanda Putra Devi Ristian Octavia Devientasari, Chinthia Devita Riafinola Dini Berliana Djamilah Arifiyana Ernawati, Iin Eziah Ika Lubada Fitria Abbas Thalib Fitriya Fitriya Fitrya Fitrya Iin Ernawati Iin Ernawati Ike Dhiah Rochmawati Indra Puspitasari Indra Puspitasari, Indra Ivan Junius Mesak Jumita Angriva Bulu Kinanti Ayu Puji Lestari Kinanti Puji Lestari Lailatus Sadiyah Luluk Aniqoh Meliana Putri Lutfiana Rakhmawati Luthfiah, Annisa Mahardiantika Industriani Putri Margarince Wungo Marviana Pisceska Njurumana Mercysca Suryandari Mercyska Suryandari Ninik Mas Ulfa Norma Nisya Nova Nur Indayanti Novita, Rennie Puspa Nur Azizah Maesie Avianti Permatasari, Silfiana Nisa Primanitha Ria Utami Primanitha Ria Utami Primanitha Ria Utami Puji, Kinanti Ayu Puput Luxfiana Sari Purnaningtyas, Sri Rahayu Dwi Purwanti, Uchti Firda Puspa Novita, Rennie Putra, Deddy Aryanda Rennie Puspa Novita Rizky Darmawan Rizky Darmawan Rizky Darmawan Rizky Darmawan Rizky Darmawan Rizky Darmawan Rizky Darmawan, Rizky Sari, Silfiana Nisa Permata Silfiana Nisa Suryandari, Mercysca Titis Wahyu Giri Suci Ulfa, Ninik Mas Utari, Yunita Winda Varel Tsania Faza Vitri Agustiarini Wa Ode Sitti Zubaydah Wardah Rahmatul Islamiyah Widya Dara Wiyan Cahyo Dwi Wicaksono Yuni Hendrawati Zakiyah , Farah Afifatuz Zulfa, Ilil Maidatuz